Evidence map›Paper›PMID 32874423›Full record

ArticleThe Pan African medical journal2020

Influenza epidemiology and risk factors for severe acute respiratory infection in Morocco during the 2016/2017 and 2017/2018 seasons.

Hind Ezzine, Imad Cherkaoui, Ahmed Rguig, Hicham Oumzil, Mouad Mrabet, Abderrahman Bimouhen, Fatima El Falaki, Zakia Regragui, Zineb Tarhda, Mohammed Youbi and 1 more

Open access · goldAbstract readHistorical Article
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hind EzzineDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Imad CherkaouiDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Ahmed RguigDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Hicham OumzilNational Influenza Center, National Institute of Hygiene, Ministry of Health, Morocco.
Mouad MrabetDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Abderrahman BimouhenNational Influenza Center, National Institute of Hygiene, Ministry of Health, Morocco.
Fatima El FalakiNational Influenza Center, National Institute of Hygiene, Ministry of Health, Morocco.
Zakia RegraguiNational Influenza Center, National Institute of Hygiene, Ministry of Health, Morocco.
Zineb TarhdaDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Mohammed YoubiDirectorate of Epidemiology and Disease Control, Ministry of Health, Morocco.
Mariam NaciriResearch Center (BIOBIO), Laboratory of Biodiversity, Ecology and Genome, Faculty of Sciences, University Mohammed V of Rabat, Morocco.
Ministère de la Santé · MAInstitut National d'Hygiène du Maroc · MAMohammed V University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionin order to implement an influenza vaccination program for high-risk-groups in Morocco, as recommended by the World Health Organization, an epidemiological study indicating the influenza virus effect in the development of complicated influenza for subjects with co-morbidity was required. The present study aims to evaluate the risk factors for severe acute respiratory infections caused by influenza in risk groups.

methodsthis research is based on the epidemiological and virological surveillance data of severe acute respiratory infections and influenza-like illness during the 2016/2017 and 2017/2018 seasons. It was realized using a retrospective series study with a descriptive and analytical purpose.

resultsthe over-recruitment of pediatric cases with a severe acute respiratory infection has been significantly rectified because cases of severe acute respiratory infections under 15 years old in the 2017/2018 season represent only 57.9%, whereas they represented 75.9% of the total cases of severe acute respiratory infections during the 2016/2017 season. The influenza positivity rate has increased globally and specifically by age group, clinical service and co-morbidity. The risk factors considered were significantly associated with hospitalization for influenza-associated severe acute respiratory infections. The multivariate logistic regression analysis considers male sex (OR=2.1), age ≥65 years (OR=5.4), presence of influenza cases in the surroundings (OR=0.1), diabetes (OR=7.5) and chronic respiratory disease (OR=10.9) as risk factors influenza-associated severe acute respiratory infections.

conclusionthe risk assessment of influenza-associated severe acute respiratory infections in high-risk groups revealed national epidemiological findings, particularly for diabetics and the elderly. An influenza vaccination program for these high-risk-groups becomes much recommended in Morocco.

Indexed as

SeasonsAcute DiseaseAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHistory, 21st CenturyHumansInfantInfant, NewbornInfluenza, HumanIntensive Care UnitsMaleco-morbidityinfluenza-like illnessInfluenza positivity rateinfluenza risk factorsevere acute respiratory infections

Identifiers

PMID32874423
PMCPMC7436631
OpenAlexW3041610264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.